Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis?

Dis Colon Rectum. 2013 Jan;56(1):14-9. doi: 10.1097/DCR.0b013e3182741929.

Abstract

Background: A multimodality approach for locally recurrent colorectal cancer in the pelvis provides a significant survival advantage when negative margins are achieved. However, outcomes of surgical resection in patients who have locally re-recurrent disease in the pelvis are not well studied. Our aim was to assess the safety, feasibility of a negative margin resection, and survival outcomes in patients with pelvic locally re-recurrent colorectal cancer.

Design: A retrospective review identified 406 patients who underwent surgery for locally recurrent colorectal cancer between 1997 and 2007. Patients who had locally re-recurrent disease in the pelvis who underwent curative-intent resection were identified.

Results: Forty-seven patients (31 male) were identified. Median age was 57 years (range, 30-84 years). Median time to re-recurrence was 2.4 years (range, 0.5-5.6 years). Margin status following re-resection was R0 60%, R1 32%, and R2 8%. Nonbowel organs were resected en bloc in 81%, including 7 sacral resections. Intraoperative radiation was given to 77%. Morbidity occurred in 42%, with 6% requiring reoperation for complications. Thirty-day mortality was nil. Overall survival at 2 and 5 years was 83% and 33%. Disease-free survival at 2 and 5 years was 55% and 27%. Five-year survival for patients who had R0 and R1 resections was 37% and 42%, whereas no patients having an R2 resection survived beyond 2 years (p = 0.002).

Conclusions: In highly selected patients with re-recurrent colorectal cancer in the pelvis, we found that surgery could be performed safely and that a curative (R0) resection was possible in more than 50%. Two- and 5-year survival rates are comparable to results seen when surgery is done for first-time recurrences.

MeSH terms

  • Adenocarcinoma* / epidemiology
  • Adenocarcinoma* / pathology
  • Adenocarcinoma* / surgery
  • Anastomosis, Surgical / adverse effects
  • Colorectal Neoplasms* / epidemiology
  • Colorectal Neoplasms* / pathology
  • Colorectal Neoplasms* / surgery
  • Disease-Free Survival
  • Female
  • Humans
  • Intraoperative Care / methods
  • Male
  • Middle Aged
  • Minnesota / epidemiology
  • Neoplasm Recurrence, Local*
  • Outcome and Process Assessment, Health Care
  • Patient Selection
  • Pelvic Exenteration* / adverse effects
  • Pelvic Exenteration* / methods
  • Pelvic Exenteration* / statistics & numerical data
  • Pelvis / pathology
  • Pelvis / surgery*
  • Radiotherapy / methods
  • Reoperation / adverse effects
  • Reoperation / methods
  • Reoperation / statistics & numerical data
  • Survivors